|Help / Recent Posts / Search / Login / Register|
Stats: 2042 Members, 4236 topics. Date: January 23, 2017, 03:40:53 PM
|Webinar - Introduction and Scale-Up of Chlorhexidine for Umbilical Cord Care - Today 4/12/2016 by katty : April 12, 2016, 03:00:15 AM|
The global Chlorhexidine Working Group is hosting a
webinar tomorrow in collaboration with the CORE Group to discuss 7.1% chlorhexidine digluconate for umbilical cord care and the progress that has been made to introduce and scale chlorhexidine for umbilical cord care in Mali, Liberia, Kenya, and Nigeria.
The webinar is free and all are welcome! Registration is
Tuesday, April 12
11:00am – 12:00pm EDT
The webinar announcement and registration link are below.
Webinar - Introduction and Scale-Up of Chlorhexidine for Umbilical Cord Care
The Webinar is brought to you by CORE Group.
Details Tuesday, April 12th, 2016; 11:00am-12:00pm EDT
Location Adobe Connect
*Patricia Coffey, PhD, MPH, Program Advisor, Devices and Tools Global Program, Group Leader, Health Technologies for Women and Children, PATH
*David Milestone, MBA, MPA, MS, Senior Market Access Advisor, Center for Accelerating Innovation and
*Mutsumi Metzler, MBA, Senior Commercialization
*Winifred Mwebesa MD MPH, Senior Director, Family
Planning/Reproductive Health, Department of Global Health,Save the Children USA
*Marion Subah, MSN, Technical Director, Jhpiego/
*Nikki Tyler, MBA, Market Access Advisor, Center for
Accelerating Innovation and Impact, USAID
Please feel free to forward this information to contacts or colleagues who may be interested in attending the
presentation tomorrow. A recording of the webinar will also be available on the CORE Group Website.
To join the session, please click the button or link
· Click the button below
· "Join as a Guest"
· Please include Name, Organization when you join
If you have never attended an Adobe Connect meeting
before, test your connection .
Each year 3 million newborns die globally, and infection
causes approximately 15% of these deaths. Poor hygiene and lack of antisepsis at birth and in the first week of life increases the risk of deadly but preventable infections.
Ensuring optimal cord care, including use of chlorhexidine,is a crucial strategy to prevent life-threatening sepsis and cord infections and avert preventable neonatal deaths.
Use of 7.1% chlorhexidine digluconate for umbilical cord
care was tested in three clinical trials in Nepal, Bangladesh,and Pakistan, which showed a 23% reduction in neonatal mortality if 7.1% chlorhexidine gluconate was used on the first day of birth.
Given these promising results, the World Health Organization (WHO) added 7.1% chlorhexidine digluconate to its Model List of Essential Medicines for
Children in 2013 and issued a new guideline on umbilical cord care in early 2014, which included a formal recommendation on the use of 7.1% chlorhexidine digluconate.
Over 25 countries are now moving forward with
chlorhexidine for umbilical cord care from stakeholder
engagement to national scale-up. The global Chlorhexidine Working Group, an international collaboration of organizations committed to advancing the use of this important life-saving drug in low-resource countries, will host a webinar to share their experiences and the different approaches that have been taken to introduce and scale-up of chlorhexidine in four countries in Sub-Saharan Africa: Kenya, Liberia, Mali, and Nigeria.
Viewing this topic: 0 Members and 1 Guest
2016 AACH ENRICH Course & Research Forum
Started by katty
March 29, 2016, 11:38:58 PM
AMCIS 2016 Information Technology for Global Health Calls for Abstract Submission
Started by katty
January 10, 2016, 01:48:28 PM